For those attending the Pharmaceutical Management Science Association Virtual Meeting December 3-4, 2020 please visit our poster on Analog Intelligence: Growing Both Players in a Duopoly Market, a case study from our growing practice in identifying and extracting learnings from analogs facing similar strategic challenges.
Poster abstract , by co-authors Haejin Chung, Former Vice President, Seqirus and our own Debbie Glick, CEO, Cello Health Advantage Inc.
Discover more about Analog Intelligence
Arsenal’s Value Demonstration Business Acquires Zipher Medical Affairs. Acquisition further strengthens market-leading medical affairs to support life sciences clients in optimizing the value of their products and accelerating patient access to medical and technological advances.
Arsenal’s Value Demonstration Business Acquires Cyan Health. Acquisition enhances market access capabilities in the U.S. to support life sciences clients in optimizing the value of their products and accelerating patient access to medical and technological advances.
On 19 November 2021, the MS21 team received a Best Practice award from the Members of the European Parliament (MEP) Interest Group on Brain, Mind and Pain, an initiative of European Federation of Neurological Associations (EFNA) and Pain Alliance Europe.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us